Publications by authors named "Francesco Carrozza"

Claim this Profile
F
First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study.
Giandomenico Roviello, Javier Molina-Cerrillo, Francesco Massari, Linda Cerbone, Ondrej Fiala, Francesco Carrozza

Cancer Immunol Immunother· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study).
Chiara Ciccarese, Thomas Büttner, Linda Cerbone, Ilaria Zampiva, Fernando Sabino M Monteiro, Francesco Carrozza

Int J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2 Study.
Ondřej Fiala, Francesco Massari, Umberto Basso, Patrizia Giannatempo, Enrique Grande, Francesco Carrozza

Target Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study.
Francesco Massari, Veronica Mollica, Ondrej Fiala, Ugo De Giorgi, Jakub Kucharz, Francesco Carrozza

Eur Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project.
Alessandro Rizzo, Fernando Sabino Marques Monteiro, Yüksel Ürün, Francesco Massari, Se Hoon Park, Francesco Carrozza

Target Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study.
Mimma Rizzo, Andrey Soares, Enrique Grande, Aristotelis Bamias, Ray Manneh Kopp, Francesco Carrozza

Sci Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of mesothelioma in young people and causal exposure to asbestos in the Italian national mesothelioma registry (ReNaM).
Alessandro Marinaccio, Davide Di Marzio, Carolina Mensi, Dario Consonni, Carmela Gioscia, Francesco Carrozza

Occup Environ Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesothelioma Risk Among Maritime Workers According to Job Title: Data From the Italian Mesothelioma Register (ReNaM).
Luigi Vimercati, Domenica Cavone, Omero Negrisolo, Floriana Pentimone, Luigi De Maria, Francesco Carrozza

Med Lav· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleural mesothelioma risk in the construction industry: a case-control study in Italy, 2000-2018.
Simona Stella, Dario Consonni, Enrica Migliore, Antonella Stura, Domenica Cavone, Francesco Carrozza

BMJ Open· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesothelioma Risk among Construction Workers According to Job Title: Data from the Italian Mesothelioma Register.
Luigi Vimercati, Domenica Cavone, Luigi De Maria, Antonio Caputi, Floriana Pentimone, Francesco Carrozza

Med Lav· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03).
Giuseppe Procopio, Mélanie Claps, Chiara Pircher, Luca Porcu, Pierangela Sepe, Francesco Carrozza

Tumori· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication.
Sebastiano Buti, Umberto Basso, Diana Giannarelli, Ugo De Giorgi, Marco Maruzzo, Francesco Carrozza

J Immunother· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asbestos Exposure and Malignant Mesothelioma in Construction Workers-Epidemiological Remarks by the Italian National Mesothelioma Registry (ReNaM).
Alessandra Binazzi, Davide Di Marzio, Marina Verardo, Enrica Migliore, Lucia Benfatto, Francesco Carrozza

Int J Environ Res Public Health· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.
Matteo Santoni, Francesco Massari, Enrique Grande, Giuseppe Procopio, Marc R Matrana, Francesco Carrozza

Target Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Orazio Caffo, Cinzia Ortega, Franco Nolè, Donatello Gasparro, Claudia Mucciarini, Francesco Carrozza

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' response: Mezei et al's "Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis".
Alessandro Marinaccio, Dario Consonni, Carolina Mensi, Dario Mirabelli, Enrica Migliore, Francesco Carrozza

Scand J Work Environ Health· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epidemiological surveillance of malignant mesothelioma in Italy (1993-2015): methods, findings, and research perspectives.
Alessandro Marinaccio, Marisa Corfiati, Alessandra Binazzi, Davide Di Marzio, Michela Bonafede, Francesco Carrozza

Epidemiol Prev· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study.
Maria Giuseppa Vitale, Stefania Pipitone, Marta Venturelli, Cinzia Baldessari, Camillo Porta, Francesco Carrozza

Clin Genitourin Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between asbestos exposure and pericardial and tunica vaginalis testis malignant mesothelioma: a case-control study and epidemiological remarks.
Alessandro Marinaccio, Dario Consonni, Carolina Mensi, Dario Mirabelli, Enrica Migliore, Francesco Carrozza

Scand J Work Environ Health· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
Melissa Bersanelli, Diana Giannarelli, Ugo De Giorgi, Sandro Pignata, Massimo Di Maio, Francesco Carrozza

Ther Adv Med Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral anticancer therapy project: Clinical utility of a specific home care nursing programme on behalf of Italian Association of Medical Oncology (AIOM).
Massimo Cirillo, Luciano Carlucci, Lorenzo Legramandi, Editta Baldini, Cosimo Sacco, Francesco Carrozza

J Clin Nurs· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors.
Matteo Santoni, Daniel Y Heng, Sergio Bracarda, Giuseppe Procopio, Michele Milella, Francesco Carrozza

Cancers (Basel)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward a genome-based treatment landscape for renal cell carcinoma.
Francesco Massari, Vincenzo Di Nunno, Matteo Santoni, Lidia Gatto, Claudia Caserta, Francesco Carrozza

Crit Rev Oncol Hematol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter concerning: 'Response to: 'The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure' by Marinaccio '.
Alessandro Marinaccio, Marisa Corfiati, Alessandra Binazzi, Davide Di Marzio, Alberto Scarselli, Francesco Carrozza

Occup Environ Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors.
Francesco Carrozza, Matteo Santoni, Francesco Piva, Liang Cheng, Antonio Lopez-Beltran

Crit Rev Oncol Hematol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis